Shimada H - Search Results

1

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.

Wang LL, Teshiba R, Ikegaki N, Tang XX, Naranjo A, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Shimada H. Wang LL, et al. Among authors: shimada h. Br J Cancer. 2015 Jun 30;113(1):57-63. doi: 10.1038/bjc.2015.188. Epub 2015 Jun 2. Br J Cancer. 2015. PMID: 26035700 Free PMC article.

2

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.

Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. Suzuki T, et al. Among authors: shimada h. J Natl Cancer Inst. 1993 Mar 3;85(5):377-84. doi: 10.1093/jnci/85.5.377. J Natl Cancer Inst. 1993. PMID: 8433391

3

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H. Goto S, et al. Among authors: shimada h. Cancer. 2001 Nov 15;92(10):2699-708. doi: 10.1002/1097-0142(20011115)92:10<2699::aid-cncr1624>3.0.co;2-a. Cancer. 2001. PMID: 11745206

4

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.

Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC. Shimada H, et al. J Natl Cancer Inst. 1995 Oct 4;87(19):1470-6. doi: 10.1093/jnci/87.19.1470. J Natl Cancer Inst. 1995. PMID: 7674334

5

High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.

Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC. Miyake M, et al. Among authors: shimada h. Prog Clin Biol Res. 1994;385:163-8. Prog Clin Biol Res. 1994. PMID: 7972208 No abstract available.

6

Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.

Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA. Sugiura Y, et al. Among authors: shimada h. Cancer Res. 1998 May 15;58(10):2209-16. Cancer Res. 1998. PMID: 9605768

7

The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.

Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, DeClerck YA. Sugiura Y, et al. Among authors: shimada h. Cancer Res. 1999 Mar 15;59(6):1327-36. Cancer Res. 1999. PMID: 10096567

8

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.

Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN. Perez CA, et al. Among authors: shimada h. J Clin Oncol. 2000 Jan;18(1):18-26. doi: 10.1200/JCO.2000.18.1.18. J Clin Oncol. 2000. PMID: 10623689 Clinical Trial.

9

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.

Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK. Schmidt ML, et al. Among authors: shimada h. J Clin Oncol. 2000 Mar;18(6):1260-8. doi: 10.1200/JCO.2000.18.6.1260. J Clin Oncol. 2000. PMID: 10715296

10

Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.

Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H. Umehara S, et al. Among authors: shimada h. Cancer. 2000 Sep 1;89(5):1150-61. Cancer. 2000. PMID: 10964346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,338 results

Search Page

Filters